COVISHIELD

A one-year follow-up study by a team of researchers at BHU revealed that nearly one-third of 926 recipients of Bharat Biotech's anti-Covid vaccine, Covaxin, reported adverse events of special interest, or AESI.

Authorities are alarmed by a surge in fraudulent activities exploiting Covid-19 vaccine inquiries, targeting unsuspecting individuals for personal information. Scammers, posing as health officials, prompt citizens for Covishield or Covaxin details, ...

Covaxin side effects: A recent study highlighted adverse events post-Bharat Biotech's Covaxin vaccinations. Led by Sankha Shubhra Chakrabarti, it noted higher risk in female adolescents and those with allergies. Of 1,024 participants, 47.9% adolesce...

Covishield Side Effects: Controversies surrounding vaccine side-effects persist despite Covid-19 waning. Covishield, developed by AstraZeneca and Oxford University, faces scrutiny in India following reports of rare side effects. Legal battles and de...

Dr. Rajeev Jayadevan, Co-Chairman of the National Indian Medical Association (IMA) Covid Task Force in Kerala, explains that Thrombosis Thrombocytopenia Syndrome (TTS), involving blood clots in rare cases, has been associated with certain vaccines, ...

The Serum Institute of India has stopped manufacturing and providing additional doses of the Covishield vaccine due to concerns about its side effects. AstraZeneca has also withdrawn its Vaxzervria vaccine and marketing authorizations within Europe....

The Serum Institute of India (SII) has stated that the safety of vaccines remains "paramount" and that all information about the side effects of its Covishield vaccine against Covid-19 was disclosed in its packaging insert in 2021. The statement com...

SII discloses TTS side-effects. Venugopalan Govindan raises Covishield concerns. Parents plan case against SII. AstraZeneca withdraws VaxAstraZeneca due to mutant variant strains.

Covishield TTS: AstraZeneca has acknowledged the potential TTS side effects from its COVID-19 vaccine Covishield, used widely in India. TTS, Thrombosis with Thrombocytopenia Syndrome, is rare but serious, marked by blood clots and low platelet level...

In a heartbreaking turn of events, the parents of Karunya, who tragically passed away in 2021 after allegedly receiving the Covishield vaccine, are seeking legal recourse. Her grieving father, Venugopalan Govindan, blames multiple parties for his da...

R Ganga Ketkar allays fears of Covid vaccine side effects, focusing on TTS. Covishield's low TTS risk 5-30 days post-vaccination. ICMR ensures post marketing surveillance. AstraZeneca dispels myths, promoting childhood vaccination.

Bharat Biotech has emphasized the safety of its Covaxin Covid vaccine, stating that it has shown excellent safety records with no vaccine-associated incidents such as blood clots or other serious side effects. The company highlighted that Covaxin wa...

Thrombosis with Thrombocytopenia Syndrome (TTS) is a dangerous condition marked by the production of blood clots and a low platelet count. Since Covishield is the Indian version of the AstraZeneca vaccine, it can cause TTS.

Covishield Vaccine: The recent admission by vaccine maker AstraZeneca in a UK court has sparked discussions about the potential side effect of Thrombosis with Thrombocytopenia Syndrome (TTS) in Covishield, leading many in India to reexamine their va...

AstraZeneca's recent disclosure about Covishield's rare but serious side effects has sparked concerns among both medical professionals and the public. This revelation, including the potential link to heart attacks and strokes, has prompted reactions...

Covishield Vaccine Row: Following AstraZeneca's acknowledgment of a rare side effect associated with its COVID-19 vaccine, known as Covishield in India, the UK pharmaceutical giant extended sympathy to those impacted. Reaffirming its dedication to p...

Covishield Vaccine Case: The parents of a woman allegedly deceased after receiving the Covishield vaccine plan to file a case against the Serum Institute of India (SII). This decision follows AstraZeneca's acknowledgment in court that their Covid sh...

UK-headquartered pharmaceutical giant AstraZeneca has admitted that in "very rare cases", its COVID-19 vaccine can cause a blood clot-related side-effect but the causal link is unknown, according to court papers being quoted in the UK media.

Covishield blood clot disease: Thrombosis Thrombocytopenia Syndrome (TTS) refers to the clot in blood vessels, and it occurs in very rare cases, following the use of certain types of vaccines